iCamuno Biotherapeutics Partners With UWA and Monash
August 01, 2024
August 01, 2024
PERTH, Australia, Aug. 1 (TNSres) -- The University of Western Australia issued the following news:
iCamuno Biotherapeutics, a pioneering biotechnology firm specialising in induced pluripotent stem cell (iPSC) technologies, has entered into a landmark patent license agreement with The University of Western Australia and Monash University.
iPSC technologies are methods used to turn regular cells into stem cells that can become any type of cell in the body, which can the . . .
iCamuno Biotherapeutics, a pioneering biotechnology firm specialising in induced pluripotent stem cell (iPSC) technologies, has entered into a landmark patent license agreement with The University of Western Australia and Monash University.
iPSC technologies are methods used to turn regular cells into stem cells that can become any type of cell in the body, which can the . . .